Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India|November 3, 2012
Concurrent cisplatin and radiotherapy in advanced head and neck cancerRehan Asif, Kamlesh Chandra, Vanita Chopra, et al.Molecular Neurobiology|May 6, 2015
Rho Kinase Pathway Alterations in the Brain and Leukocytes in Huntington's DiseaseK Lakshmi Narayanan, Vanita Chopra, H Diana Rosas, et al.Journal of Huntington'S Disease|December 17, 2016
LBH589, A Hydroxamic Acid-Derived HDAC Inhibitor, is Neuroprotective in Mouse Models of Huntington's DiseaseVanita Chopra, Luisa Quinti, Prarthana Khanna, et al.Analytical Biochemistry|February 19, 2013
A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington diseaseBeena Thomas, Samantha Matson, Vanita Chopra, et al.Proceedings of the National Academy of Sciences of the United States of America|October 11, 2007
A small-molecule therapeutic lead for Huntington's disease: preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouseVanita Chopra, Jonathan H Fox, Greg Lieberman, et al.Plos One|March 31, 2007
Mechanisms of copper ion mediated Huntington's disease progressionJonathan H Fox, Jibrin A Kama, Gregory Lieberman, et al.Human Molecular Genetics|July 28, 2011
The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNSMichele M Maxwell, Elizabeth M Tomkinson, Johnathan Nobles, et al.Plos One|January 24, 2017
Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer's DiseaseKsenia V Kastanenka, Steven S Hou, Naomi Shakerdge, et al.Neurobiology of Disease|July 12, 2014
Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse modelZhen Lu, Eileen Marks, Jianfang Chen, et al.Molecular Neurodegeneration|June 24, 2010
The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's diseaseJonathan H Fox, Teal Connor, Vanita Chopra, et al.Pageof 2